ATRenew (RERE) Research & Development (2020 - 2026)

ATRenew has reported Research & Development for 7 years, with the latest figure at -$10.6 million in Q1 2026.

• Quarterly Research & Development fell 40.63% year-over-year to -$10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$127.5 million (up 16.54% YoY) and the FY2025 annual result came in at $34.9 million, up 30.71% from the prior year.
• Research & Development fell to -$10.6 million in Q1 2026 per RERE's latest filing, from -$9.0 million in the prior quarter.
• Over five years, Research & Development peaked at -$7.6 million in Q1 2025 and troughed at -$86.1 million in Q4 2022.
• A 5-year average of -$42.7 million and a median of -$44.9 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2025: Research & Development tumbled 48.83% in 2022, then surged 83.0% in 2025.
• Over 5 years, Research & Development stood at -$86.1 million in 2022, then surged by 48.16% to -$44.7 million in 2023, then fell by 15.49% to -$51.6 million in 2024, then soared by 82.64% to -$9.0 million in 2025, then fell by 18.84% to -$10.6 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$10.6 million, -$9.0 million, and -$51.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.